Integer Holdings Reports Q2 2025 Earnings: Strong Revenue Growth Amid Mixed Financial Results

Integer Holdings Corporation (NYSE: ITGR) - Q2 2025 Earnings Overview

Integer Holdings Corporation, a leader in medical device contract development and manufacturing, announced its financial results for the second quarter ended June 27, 2025. Below are the key highlights from the income statement.

Positive Aspects:

• Quarterly Revenue Growth: Sales increased by 11.4% to $476.5 million compared to $427.9 million in Q2 2024, driven by strong demand and contributions from recent acquisitions.
• Gross Profit: Gross profit rose to $129.2 million, up 10% year-over-year.
• Operating Income: Operating income showed an increase of 8.9%, reaching $59.3 million.
• Interest Expense Reduction: Interest expense dropped by 33% to $9.8 million from $14.6 million, attributed to lower interest rates despite a higher debt balance.
• Solid Liquidity Position: The company maintained a strong current ratio of 3.41, indicating good short-term financial stability.
• Stockholders' Equity Growth: Total stockholders' equity increased from $1.619 billion at year-end 2024 to $1.704 billion.

Negative Aspects:

• Decreased Net Income: Net income was $37.0 million, or $1.04 per diluted share, down from $51.8 million, or $1.47 per diluted share in the previous year's same quarter.
• Higher Operating Expenses: Total operating expenses rose to $69.8 million, up by 11%, primarily due to increased selling, general, and administrative expenses (SG&A).
• Loss from Discontinued Operations: There were no substantial losses reported from discontinued operations, but overall income from discontinued activities was nominal.
• Unfavorable Tax Provision: The provision for income taxes was $18.1 million, reflecting an effective tax rate of 55.4%, significantly higher than the previous year's first half rate of 20.2%.
• Other (Income) Loss: The company recorded significant losses in other income, totaling $51.9 million, mainly due to a $46.7 million debt conversion inducement expense.

Statistics Summary:

• Sales: Q2 2025 - $476.5 million; Q2 2024 - $427.9 million.
• Gross Profit: Q2 2025 - $129.2 million; Q2 2024 - $117.4 million.
• Operating Income: Q2 2025 - $59.3 million; Q2 2024 - $54.5 million.
• Net Income: Q2 2025 - $37.0 million; Q2 2024 - $51.8 million.
• Earnings Per Share (EPS): Q2 2025 - $1.04 diluted; Q2 2024 - $1.47 diluted.
• Total Assets: $3.37 billion as of June 27, 2025.
• Total Liabilities: $1.67 billion as of June 27, 2025.

This mixed performance illustrates the challenges faced by Integer amidst an evolving market landscape while highlighting areas of growth and strength in operations. The impact of operational adjustments and market conditions will be pivotal in driving future performance.